Biodistribution and biopersistence of ceria engineered nanomaterials: Size dependence

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 9, Issue 3, 2013, Pages 398-407

  Yokel, Robert A ^a   Tseng, Michael T ^b   Dan, Mo ^a   Unrine, Jason M ^a   Graham, Uschi M ^a   Wu, Peng ^a   Grulke, Eric A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

Biodistribution; Brain; Ceria; Persistence; Rats

Indexed keywords

BIODISTRIBUTIONS; BRAIN DELIVERY; BRAIN PARENCHYMA; CENTRAL NERVOUS SYSTEMS; ENGINEERED NANOMATERIALS; NANO-CERIA; PERSISTENCE; SIZE DEPENDENCE;

BRAIN; CERIUM COMPOUNDS; MEDICAL NANOTECHNOLOGY; NANOSTRUCTURED MATERIALS; NANOTECHNOLOGY;

RATS;

ANTIOXIDANT; CERIUM OXIDE; NANOCERIA; NANOMATERIAL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG LIVER LEVEL; DRUG PENETRATION; DRUG UPTAKE; MALE; NONHUMAN; PARTICLE SIZE; RAT; SPLEEN;

ANIMALS; CERIUM; LIVER; MALE; NANOSTRUCTURES; NANOTECHNOLOGY; PARTICLE SIZE; RATS; RATS, SPRAGUE-DAWLEY; SCATTERING, RADIATION; SPLEEN; TISSUE DISTRIBUTION;

RATTUS;

EID: 84875531067     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2012.08.002     Document Type: Article

References (53)

1. Cassee F.R., van Balen E.C., Singh C., Green D., Muijser H., Weinstein J., et al. Exposure, health and ecological effects review of engineered nanoscale cerium and cerium oxide associated with its use as a fuel additive. Crit Rev Toxicol 2011, 41:213-229.
2. Hirst S.M., Karakoti A., Singh S., Self W., Tyler R., Seal S., et al. Bio-distribution and in vivo antioxidant effects of cerium oxide nanoparticles in mice. Environ Toxicol 2011, 1-12.
3. He X., Zhang H., Ma Y., Bai W., Zhang Z., Lu K., et al. Lung deposition and extrapulmonary translocation of nano-ceria after intratracheal instillation. Nanotechnology 2010, 21. 285103/1-/8.
4. Park E.-J., Park Y.-K., Park K. Acute toxicity and tissue distribution of cerium oxide nanoparticles by a single oral administration in rats. Toxicol Res 2009, 25:79-84.
5. Geraets L., Oomen A.G., Schroeter J.D., Coleman V.A., Cassee F.R. Tissue distribution of inhaled micro- and nano-sized cerium oxide particles in rats: results from a 28-day exposure study. Toxicol Sci 2012, 127:463-473.
6. Hirst S.M., Karakoti A.S., Tyler R.D., Sriranganathan N., Seal S., Reilly C.M. Anti-inflammatory properties of cerium oxide nanoparticles. Small 2009, 5:2848-2856.
7. Yokel R.A., Florence R.L., Unrine J.M., Tseng M.T., Graham U.M., Wu P., et al. Biodistribution and oxidative stress effects of a systemically-introduced commercial ceria engineered nanomaterial. Nanotoxicology 2009, 3:234-248.
8. Yokel R.A., Au T.C., MacPhail R., Hardas S.S., Butterfield D.A., Sultana R., et al. Distribution, elimination and biopersistence to 90 days of a systemically-introduced 30 nm ceria engineered nanomaterial in rats. Toxicol Sci 2012, 127:256-268.
9. Dan M., Wu P., Grulke E.A., Graham U.M., Unrine J.M., Yokel R.A. Ceria engineered nanomaterial distribution in and clearance from blood: size matters. Nanomedicine 2012, 7:95-110.
10. Tseng M.T., Lu X., Duan X., Hardas S.S., Sultana R., Wu P., et al. Alteration of hepatic structure and oxidative stress induced by intravenous nanoceria. Toxicol Appl Pharmacol 2012, 260:173-182.
11. Hackley V.A., Ferraris C.F. The use of nomenclature in dispersion science and technology. Technology NIoSa 2001, 72.
12. Safi M., Sarrouj H., Sandre O., Mignet N., Berret J.F. Interactions between sub-10-nm iron and cerium oxide nanoparticles and 3T3 fibroblasts: the role of the coating and aggregation state. Nanotechnology 2010, 21:145103.
13. Ohno K., Pettigrew K.D., Rapoport S.I. Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat. Am J Physiol 1978, 235:H299-H307.
14. Takasato Y., Rapoport S.I., Smith Q.R. An in situ brain perfusion technique to study cerebrovascular transport in the rat. Am J Physiol 1984, 247:H484-H493.
15. Triguero D., Buciak J., Pardridge W.M. Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins. J Neurochem 1990, 54:1882-1888.
16. Dan M., Tseng M.T., Wu P., Unrine J.M., Grulke E.A., Yokel R.A. Brain microvascular endothelial cell association and distribution of a 5 nm ceria engineered nanomateria. Int J Nanomedicine 2012, 7:4023-4036.
17. Zhu H.D., Wang J.Y., Wu Q., Wang N.F., Fan T.J., Liu H.S., Liu Q.F., et al. Elemental contents in organs and tissues of Chinese adult men. Chin Med Sci J 2007, 22:71-82.
18. Patel M.M., Goyal B.R., Bhadada S.V., Bhatt J.S., Amin A.F. Getting into the brain: approaches to enhance brain drug delivery. CNS Drugs 2009, 23:35-58.
19. Choi H.S., Liu W., Misra P., Tanaka E., Zimmer J.P., Itty Ipe B., et al. Renal clearance of quantum dots. Nat Biotechnol 2007, 25:1165-1170.
20. Ballou B., Lagerholm B.C., Ernst L.A., Bruchez M.P., Waggoner A.S. Noninvasive imaging of quantum dots in mice. Bioconjug Chem 2004, 15:79-86.
21. Fischer H.C., Liu L., Pang K.S., Chan W.C.W. Pharmacokinetics of nanoscale quantum dots: in vivo distribution, sequestration, and clearance in the rat. Adv Funct Mater 2006, 16:1299-1305.
22. Yang R.S., Chang L.W., Wu J.P., Tsai M.H., Wang H.J., Kuo Y.C., et al. Persistent tissue kinetics and redistribution of nanoparticles, quantum dot 705, in mice: ICP-MS quantitative assessment. Environ Health Perspect 2007, 115:1339-1343.
23. Lin P., Chen J.W., Chang L.W., Wu J.P., Redding L., Chang H., et al. Computational and ultrastructural toxicology of a nanoparticle, Quantum Dot 705, in mice. Environ Sci Technol 2008, 42:6264-6270.
24. 2 and quartz. Toxicol Lett 2009, 186:152-159.
25. Cho W.S., Cho M., Jeong J., Choi M., Cho H.Y., Han B.S., et al. Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol Appl Pharmacol 2009, 236:16-24.
26. dos Santos Silva I., Malveiro F., Jones M.E., Swerdlow A.J. Mortality after radiological investigation with radioactive Thorotrast: a follow-up study of up to fifty years in Portugal. Radiat Res 2003, 159:521-534.
27. Cho W.-S., Cho M.-J., Jeong J.-Y., Choi M.-N., Han B.-S., Shin H.-S., et al. Size-dependent tissue kinetics of PEG-coated gold nanoparticles. Toxicol Appl Pharmacol 2010, 245:116-123.
28. Yokel Robert A., Grulke Eric A., MacPhail R.C. Metal-based nanoparticle interactions with the nervous system: the challenge of brain entry and the risk of retention in the organism. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2012, invited review, revision to be submitted August 17, 2012.
29. Dowding J.M., Dosani T., Kumar A., Seal S., Self W.T. Cerium oxide nanoparticles scavenge nitric oxide radical (√NO). Chem Commun (Cambridge, U K) 2012, 48:4896-4898.
30. Tarnuzzer R.W., Colon J., Patil S., Seal S. Vacancy engineered ceria nanostructures for protection from radiation-induced cellular damage. Nano Lett 2005, 5:2573-2577.
31. Colon J., Herrera L., Smith J., Patil S., Komanski C., Kupelian P., et al. Protection from radiation-induced pneumonitis using cerium oxide nanoparticles. Nanomedicine 2009, 5:225-231.
32. Colon J., Hsieh N., Ferguson A., Kupelian P., Seal S., Jenkins D.W., et al. Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2. Nanomedicine 2010, 6:698-705.
33. Clark A., Zhu A., Sun K., Petty H.R. Cerium oxide and platinum nanoparticles protect cells from oxidant-mediated apoptosis. J Nanopart Res 2011, 13:5547-5555.
34. Pagliari F., Mandoli C., Forte G., Magnani E., Pagliari S., Nardone G., et al. Cerium oxide nanoparticles protect cardiac progenitor cells from oxidative stress. ACS Nano 2012, 6:3767-3775.
35. Niu J., Wang K., Kolattukudy P.E. Cerium oxide nanoparticles inhibit oxidative stress and nuclear factor-kappaB activation in H9c2 cardiomyocytes exposed to cigarette smoke extract. J Pharmacol Exp Ther 2011, 338:53-61.
36. 2 nanoparticles on A549 cells. Hebei Daxue Xuebao, Ziran Kexueban 2011, 31:160-166.
37. Lin W., Huang Y.W., Zhou X.D., Ma Y. Toxicity of cerium oxide nanoparticles in human lung cancer cells. Int J Toxicol 2006, 25:451-457.
38. Schubert D., Dargusch R., Raitano J., Chan S.W. Cerium and yttrium oxide nanoparticles are neuroprotective. Biochem Biophys Res Commun 2006, 342:86-91.
39. D'Angelo B., Santucci S., Benedetti E., Di Loreto S., Phani R.A., Falone S., et al. Cerium oxide nanoparticles trigger neuronal survival in a human Alzheimer disease model by modulating BDNF pathway. Curr Nanosci 2009, 5:167-176.
40. Das M., Patil S., Bhargava N., Kang J.F., Riedel L.M., Seal S., et al. Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. Biomaterials 2007, 28:1918-1925.
41. Singh N., Cohen C.A., Rzigalinski B.A. Treatment of neurodegenerative disorders with radical nanomedicine. Ann N Y Acad Sci 2007, 1122:219-230.
42. Estevez A.Y., Pritchard S., Harper K., Aston J.W., Lynch A., Lucky J.J., et al. Neuroprotective mechanisms of cerium oxide nanoparticles in a mouse hippocampal brain slice model of ischemia. Free Radic Biol Med 2011, 51:1155-1163.
43. Brunner T.J., Wick P., Manser P., Spohn P., Grass R.N., Limbach L.K., et al. In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. Environ Sci Technol 2006, 40:4374-4381.
44. Park E.J., Choi J., Park Y.K., Park K. Oxidative stress induced by cerium oxide nanoparticles in cultured BEAS-2B cells. Toxicology 2008, 245:90-100.
45. 2 nanoparticles via p38-Nrf-2 signaling pathway in human bronchial epithelial cell, Beas-2B. Toxicol Lett 2009, 187:77-83.
46. Chen J., Patil S., Seal S., McGinnis J.F. Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides. Nat Nanotechnol 2006, 1:142-150.
47. Zhou X., Wong L.L., Karakoti A.S., Seal S., McGinnis J.F. Nanoceria inhibit the development and promote the regression of pathologic retinal neovascularization in the Vldlr knockout mouse. PLoS One 2011, 6:e16733.
48. Kong L., Cai X., Zhou X., Wong L.L., Karakoti A.S., Seal S., et al. Nanoceria extend photoreceptor cell lifespan in tubby mice by modulation of apoptosis/survival signaling pathways. Neurobiol Dis 2011, 42:514-523.
49. Amin K.A., Hassan M.S., Awad el S.T., Hashem K.S. The protective effects of cerium oxide nanoparticles against hepatic oxidative damage induced by monocrotaline. Int J Nanomedicine 2011, 6:143-149.
50. Niu J., Azfer A., Rogers L.M., Wang X., Kolattukudy P.E. Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy. Cardiovasc Res 2007, 73:549-559.
51. Park E.-J.C., Wan-Seob, Jeong J., Yi J.-h., Choi K., Kim Y., et al. Induction of inflammatory responses in mice treated with cerium oxide nanoparticles by intratracheal instillation. JHealth Sci 2010, 56:387-396.
52. Srinivas A., Rao P.J., Selvam G., Murthy P.B., Reddy P.N. Acute inhalation toxicity of cerium oxide nanoparticles in rats. Toxicol Lett 2011, 205:105-115.
53. Hardas S.S., Sultana R., Warrier G., Dan M.F., R.L., Wu P., Grulke E.A., et al. Rat brain pro-oxidant effects of peripherally administered 5 nm ceria 30 days after exposure. Neurotoxicology 2012.